Repligen Corporation (RGEN)

Nasdaq · Healthcare · Medical Instruments & Supplies
$163.81-3.81%As of 2026-11-22 · USD
Last session low $162.50Last session high $169.61
52-week low $100.9952-week high $198.87
Market cap
$10.47B
Sector
Healthcare
P/E (TTM)
over 200x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)44.6In the neutral range (30 to 70)
MACD (12, 26, 9)-2.79Below its signal line (-2.18); histogram -0.61
Bollinger %B (20, 2)13%Inside the bands (160.19 to 187.01)
SMA 20173.60Price is 5.6% below
SMA 50177.22Price is 7.6% below
SMA 200145.76Price is 12.4% above
ATR (20)4.98% of priceAverage true range per day
52-week position64%In the middle of the 100.99 to 198.87 range

About Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Insider filings, 90 daysNo purchases and 4 sales (about $5.0M).
Latest fiscal yearEnded 2025-12-31: revenue of $738.26M and an operating margin of 5.6%.

More in Medical Instruments & Supplies